We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Switzerland's Federal Council is to review its pharmacy payments system in the wake of changes to the framework whereby health funds compensate drug retailers.
In the 12 months since choosing to locate its U.S headquarters in Wayne, Pa.,
Shire Pharmaceuticals has grown from 10 employees to nearly 500 at the Chester
County site.
From being an import-dependent industry in the 1950s, the Indian pharmaceuticals
sector has come a long way to become the $7 billion giant it is today.
Pharma major Zydus Cadila has entered into a 50:50 joint venture with Australia-based Mayne Pharma to manufacture generic injectible, cytotoxic (anti-cancer) medicines as well as bulk drugs for global markets.
Morphotek Inc. entered into a research and collaboration agreement with GlaxoSmithKline plc to generate cell lines that exhibit new or improved biological characteristics.
Celgene, the U.S. group best
known for reviving thalidomide as a treatment for cancer, is keen to buy a European
company to increase its global reach, Chief Executive John Jackson said on Thursday.
Israel's generic drugmakers and representatives of the research-based industry have both submitted their own draft intellectual property laws to the country's legislature.
Mexican drugmaker QUIFA has called on the government to publish rules obliging
firms to demonstrate product bioequivalence and bioavailability for new generics.